Literature DB >> 2107525

Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancer.

K Nelms1, R Hromas, B Van Ness.   

Abstract

Control of kappa immunoglobulin light-chain gene expression requires the interaction of tissue specific and developmentally regulated DNA-binding proteins with the kappa gene enhancer. Deletion of enhancer sequences upstream from the NF-kB binding site has been shown to impair enhancer function, implying additional proteins may interact with these sequences. In surveying this region for sites of protein binding, a novel DNA-protein interaction, designated kBF-A, was detected. The binding activity of this factor appears to be specific to activated pre-B cells and correlates with high level induction of kappa transcription in these cells.

Mesh:

Substances:

Year:  1990        PMID: 2107525      PMCID: PMC330361          DOI: 10.1093/nar/18.4.1037

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

2.  Purified mu EBP-E binds to immunoglobulin enhancers and promoters.

Authors:  C L Peterson; S Eaton; K Calame
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

3.  The SV40 enhancer contains two distinct levels of organization.

Authors:  B Ondek; L Gloss; W Herr
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

4.  Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.

Authors:  J W Pierce; M Lenardo; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Fine mapping of an immunoglobulin gene activator.

Authors:  C Queen; J Stafford
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

6.  A conserved sequence in the immunoglobulin J kappa-C kappa intron: possible enhancer element.

Authors:  L Emorine; M Kuehl; L Weir; P Leder; E E Max
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

7.  Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells.

Authors:  A Rodriguez-Pena; E Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

8.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

9.  Identification and partial purification of a protein binding to the human immunoglobulin kappa enhancer kappa E2 site.

Authors:  J M Gimble; J R Flanagan; D Recker; E E Max
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

10.  Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription.

Authors:  M L Atchison; R P Perry
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  19 in total

Review 1.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

2.  Identification of an octamer-binding site in the human kappa light-chain enhancer.

Authors:  K Nelms; B Van Ness
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

4.  Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.

Authors:  C M Rudin; U Storb
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

5.  Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation.

Authors:  C L Miller; A L Feldhaus; J W Rooney; L D Rhodes; C H Sibley; H Singh
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  Silencing of the expression of the immunoglobulin kappa gene in non-B cells.

Authors:  J W Pierce; A M Gifford; D Baltimore
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

7.  Octamer independent activation of transcription from the kappa immunoglobulin germline promoter.

Authors:  A Prabhu; D P O'Brien; G L Weisner; R Fulton; B Van Ness
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

8.  Two different IFN-gamma nonresponsive variants derived from the B-cell lymphoma 70Z/3.

Authors:  L D Rhodes; A T Paull; C H Sibley
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  Negative regulation of immunoglobulin kappa light-chain gene transcription by a short sequence homologous to the murine B1 repetitive element.

Authors:  K Saksela; D Baltimore
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Authors:  HaiDan Liu; Hui Zheng; Zhi Duan; DuoSha Hu; Ming Li; SuFang Liu; ZiJian Li; XiYun Deng; ZhenLian Wang; Min Tang; Ying Shi; Wei Yi; Ya Cao
Journal:  Mol Cancer       Date:  2009-10-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.